CNTO 5825

· Centocor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNTO 5825, covering 2010-10-01 to 2010-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Intravenous and Subcutaneous Administration of a Human Monoclonal Antibody (CNTO 5825) in Healthy Volunteers [Phase 1]

See pricing